R1 RCM (NASDAQ:RCM) Announces Quarterly Earnings Results

R1 RCM (NASDAQ:RCM) released its earnings results on Tuesday. The healthcare provider reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.04), Briefing.com reports. The firm had revenue of $656.80 million during the quarter, compared to the consensus estimate of $640.93 million. R1 RCM had a negative net margin of 1.68% and a negative return on equity of 1.44%. The business’s revenue for the quarter was up 14.7% on a year-over-year basis.

R1 RCM Price Performance

Shares of RCM stock traded up $0.01 on Thursday, hitting $14.28. 2,613,925 shares of the company’s stock were exchanged, compared to its average volume of 3,478,269. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.84 and a quick ratio of 1.84. R1 RCM has a 12 month low of $8.87 and a 12 month high of $15.12. The stock has a market cap of $6.03 billion, a P/E ratio of -95.13 and a beta of 0.84. The company has a 50 day moving average of $14.18 and a 200 day moving average of $13.29.

Analyst Ratings Changes

RCM has been the topic of several research reports. Leerink Partners cut R1 RCM from an “outperform” rating to a “market perform” rating and cut their target price for the company from $17.00 to $14.30 in a research note on Thursday, August 1st. Jefferies Financial Group lowered R1 RCM from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Leerink Partnrs lowered R1 RCM from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $14.30 price target on shares of R1 RCM in a research report on Friday, October 4th. Finally, TD Cowen reaffirmed a “hold” rating and set a $14.30 price target (down previously from $20.00) on shares of R1 RCM in a research report on Monday, August 5th. Thirteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $15.41.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.